Skip to content

Contact +44 (0) 20 7060 7474 email us

Clinical Trials

Metered Dose Inhalers Clinical Trial Analysis

 

Publication Date July 2009
Publisher Global Markets Direct
Product Type
Pages 18
ISBN Number not applicable
Product Code GMD02914

Price

£670.00
approximately: $998 | €735

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Global Markets Direct's "Metered Dose Inhalers Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Metered Dose Inhalers manufacturers, globally. The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.

Scope

  • The report provides analysis and review of the key clinical trials being carried out globally and across key Metered Dose Inhalers market categories - Metered Dose Inhalers
  • The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc.
  • The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results
  • The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy

  • Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.
  • Stay ahead of the information curve in the fast changing Metered Dose Inhalers market.
  • Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.
  • Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Contents

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Metered Dose Inhalers Clinical Trials
    • 2.1 Metered Dose Inhalers Clinical Trial By Equipment Type
    • 2.2 Metered Dose Inhalers Clinical Trials By Trial Phase and Trial Status
    • 2.3 Metered Dose Inhalers Pipeline Products By Development Stage
    • 2.4 Metered Dose Inhalers Pipeline Products By Therapy Area
    • 2.5 Metered Dose Inhalers Budesonide Clickhaler
      • 2.5.1 Efficacy And Tolerability Of Budesonide Clickhaler And Turbuhaler In Adult Asthma
      • 2.5.2 Assessment Of Adrenal Suppression From Two New Dry Powder Inhaler Formulations Of Budesonide Delivered By Clickhaler Compared With The Pulmicort Turbuhaler
      • 2.5.3 Gamma Scintigraphic Evaluation Of A Novel Budesonide Dry Powder Inhaler Using A Validated Radiolabeling Technique
      • 2.5.4 Bioavailability Of The Budesonide Delivered By The Clickhaler And Turbuhaler Dry Powder Inhalers In Healthy Volunteers: A Pilot Study
  • 3 Recent Developments
    • 3.1 Product News
      • 3.1.1 Jan 15, 2009: Teva Specialty Pharmaceuticals Donates ProAir HFA To Direct Relief International Help Economically Disadvantaged Asthma Sufferers Breathe Easier
      • 3.1.2 Oct 24, 2007: Bang & Olufsen Medicom Presents Positive Data For Inhalers
  • 4 Appendix
    • 4.1 Methodology
      • 4.1.1 Coverage
      • 4.1.2 Secondary Research
      • 4.1.3 Primary Research
      • 4.1.4 Expert Panel Validation
    • 4.2 Contact Us
    • 4.3 About Global Markets Direct
    • 4.4 Disclaimer
  • 1 List of Tables
    • Table 1: Metered Dose Inhalers Clinical Trial By Equipment Type
    • Table 2: Metered Dose Inhalers Clinical Trials By Trial Phase and Trial Status
    • Table 3: Metered Dose Inhalers Pipeline Products By Development Stage
    • Table 4: Metered Dose Inhalers Pipeline Products By Therapy Area
    • Table 5: Budesonide Clickhaler - Efficacy And Tolerability Of Budesonide Clickhaler And Turbuhaler In Adult Asthma
    • Table 6: Budesonide Clickhaler - Assessment Of Adrenal Suppression From Two New Dry Powder Inhaler Formulations Of Budesonide Delivered By Clickhaler Compared With The Pulmicort Turbuhaler
    • Table 7: Budesonide Clickhaler - Gamma Scintigraphic Evaluation Of A Novel Budesonide Dry Powder Inhaler Using A Validated Radiolabeling Technique
    • Table 8: Budesonide Clickhaler - Bioavailability Of The Budesonide Delivered By The Clickhaler And Turbuhaler Dry Powder Inhalers In Healthy Volunteers: A Pilot Study
  • 1.2 List of Figures
    • Figure 1: Global Markets Direct Methodology